Hindustan Syringes shuts plant owing to pollution, triggers shortage scare

Last Updated on January 31, 2023 by Admin


The closure of needles and syringes manufacturing factories located in Haryana’s Faridabad, adjoining Delhi, as a part of controlling emissions in the NCR will impact healthcare delivery across the country in general and the Covid-19 vaccination programme in particular, said a top official of Devices Ltd (HMD).

“We have been asked to shut down our needles and syringes plants in Faridabad along with the factories of several other companies,” HMD Managing Director Rajiv Nath told IANS.

“We daily produce 1.5 crore needles and 80 lakh syringes. This has come to a halt now. As we can’t feed needles beyond two days buffer stock from Monday, other factories fed by the mother unit will be shut and daily 1.2 crore syringes will not be available nationally,” he said.

According to him, syringes are already running short in India and globally and the government has put in export restrictions.

The expectation was that the export restriction will be lifted by December end as peak demand ebbed post Diwali, he added.

Nath, who is also the Forum Coordinator of Association of Indian Devices Industry, in a letter to Prime Minister Narendra Modi, urged that syringes manufacturing facilities be declared as making products of national importance under the National Disaster Management Act.

He said the power supply from Haryana’s power utility is stable and most of the company’s gensets are powered by environmentally friendly piped natural gas.

Only small plants of HMD are connected to diesel gensets, Nath added.

He said HMD contributes over 66 per cent of India’s syringes supplies for curative healthcare and immunisation.

Disruption in the supply chain would result in shortage and other related issues like price increases.



(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

mail Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor


Source link